Vishria Bird Financial Group, LLC Gilead Sciences, Inc. Transaction History

Vishria Bird Financial Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 09, 2020	SELL	$61.62 - $67.78 $4.29 Million - $4.72 Million	-69,676 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$62.51 - $69.0 $282,982 - $312,363	4,527 Added 6.95%	69,676 $4.42 Million
Q2 2019 Jul 15, 2019	BUY	$61.87 - $69.38 $293,573 - $329,208	4,745 Added 7.86%	65,149 $4.4 Million
Q1 2019 Apr 05, 2019	SELL	$62.53 - $70.05 $52,212 - $58,491	-835 Reduced 1.36%	60,404 $3.93 Million
Q4 2018 Jan 17, 2019	BUY	$60.54 - $79.0 $12,108 - $15,800	200 Added 0.33%	61,239 $3.83 Million

Q3 2018 Oct 30, 2018	BUY	$71.28 - $78.92 $16,750 - $18,546	235 Added 0.39%	61,039 $4.71 Million
Q2 2018 Aug 06, 2018	BUY	$64.88 - $75.68 $3.94 Million - $4.6 Million	60,804 New	60,804 $4.31 Million

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Vishria Bird Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Vishria Bird Financial Group, LLC with notifications on news.